Cargando…

Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway

Xuezhikang (XZK), an extract of Chinese red yeast rice, is recommended as an optimal choice for patients with coronary heart disease (CHD) with markedly elevated triglyceride (TG) levels. This study was designed to compare the hypotriglyceridemic effects between XZK and simvastatin. The role of apol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shui-ping, Li, Rong, Dai, Wen, Yu, Bi-lian, Chen, Lu-zhu, Huang, Xian-sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608289/ https://www.ncbi.nlm.nih.gov/pubmed/28934253 http://dx.doi.org/10.1371/journal.pone.0184949

Ejemplares similares

Apolipoprotein A5 regulates intracellular triglyceride metabolism in adipocytes
por: Zheng, Xiao-Yan, et al.
Publicado: (2017)

Effects of Xuezhikang versus Pravastatin on Triglyceride Level in Patients with T2DM and Dyslipidemia: Study Protocol for a Multicenter Randomized Controlled Trial
por: Xu, Jin, et al.
Publicado: (2023)

Effects of simvastatin on apolipoprotein M in vivo and in vitro
por: Zhang, Xiaoying, et al.
Publicado: (2011)

Xuezhikang reduced arterial stiffness in patients with essential hypertension: a preliminary study
por: Zheng, J., et al.
Publicado: (2017)

Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
por: Guan, Yunpeng, et al.
Publicado: (2021)

Comparison of the Reductions in LDL-C and Non-HDL-C Induced by the Red Yeast Rice Extract Xuezhikang Between Fasting and Non-fasting States in Patients With Coronary Heart Disease
por: Zhu, Li-Yuan, et al.
Publicado: (2021)

Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans
por: Xu, Rui-Xia, et al.
Publicado: (2017)

Large triglyceride-rich lipoproteins in hypertriglyceridemia are associated with the severity of acute pancreatitis in experimental mice
por: Zhang, Yue, et al.
Publicado: (2019)

Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2014)

Effects of different triglyceride-lowering therapies in patients with hypertriglyceridemia-induced acute pancreatitis
por: Yu, Shanshan, et al.
Publicado: (2020)

Lipoprotein Lipase/Apolipoprotein Cll Gene Polymorphism in Kurdish Patients With Severe Hypertriglyceridemia
por: Hussein, Kajeen, et al.
Publicado: (2023)

Simvastatin and Losartan Differentially and Synergistically Inhibit Atherosclerosis in Apolipoprotein E(-/-) Mice
por: Lee, Bok-Soo, et al.
Publicado: (2012)

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
por: Ahmad, Zahid, et al.
Publicado: (2019)

Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia
por: Sun, Cathy J, et al.
Publicado: (2019)

A Systematic Review of Xuezhikang, an Extract from Red Yeast Rice, for Coronary Heart Disease Complicated by Dyslipidemia
por: Shang, Qinghua, et al.
Publicado: (2012)

Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails
por: Li, Min, et al.
Publicado: (2015)

Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
por: Li, Yan-hong, et al.
Publicado: (2014)

Determination of the Optimal Cutoff Value of Triglyceride That Corresponds to Fasting Levels in Chinese Subjects With Marked Hypertriglyceridemia
por: Guo, Li-Ling, et al.
Publicado: (2021)

Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2021)

Genetic variants in Apolipoprotein AV alter triglyceride concentrations in pregnancy
por: Ward, Kirsten J, et al.
Publicado: (2003)

Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
por: Yu, Bi-lian, et al.
Publicado: (2012)

A Systems Approach Dissociates Fructose-Induced Liver Triglyceride from Hypertriglyceridemia and Hyperinsulinemia in Male Mice
por: Doridot, Ludivine, et al.
Publicado: (2021)

PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
por: Feng, Xiaomeng, et al.
Publicado: (2016)

Apolipoprotein C3 is negatively associated with estrogen and mediates the protective effect of estrogen on hypertriglyceridemia in obese adults
por: Li, Jinman, et al.
Publicado: (2023)

Overexpression of apolipoprotein C‐III decreases secretion of dietary triglyceride into lymph
por: Wang, Fei, et al.
Publicado: (2014)

The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
por: Yassine, Hussein N., et al.
Publicado: (2015)

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism
por: Luo, Mengdie, et al.
Publicado: (2016)

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis
por: Whitacre, Brynne E., et al.
Publicado: (2021)

Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
por: Csomó, Krisztián, et al.
Publicado: (2022)

Xuezhikang, Extract of Red Yeast Rice, Improved Abnormal Hemorheology, Suppressed Caveolin-1 and Increased eNOS Expression in Atherosclerotic Rats
por: Zhu, Xin-Yuan, et al.
Publicado: (2013)

Xuezhikang, an extract from red yeast rice, attenuates vulnerable plaque progression by suppressing endoplasmic reticulum stress-mediated apoptosis and inflammation
por: Shen, Linghong, et al.
Publicado: (2017)

Effect of a low‐fat diet on serum triglyceride and cholesterol concentrations and lipoprotein profiles in Miniature Schnauzers with hypertriglyceridemia
por: Xenoulis, Panagiotis G., et al.
Publicado: (2020)

Plasmapheresis can correct refractoriness of insulin on triglyceride metabolism – A case report of hypertriglyceridemia-induced acute pancreatitis
por: Sundaram, Bala, et al.
Publicado: (2023)

Hypertriglyceridemia
por: Brahm, Amanda, et al.
Publicado: (2013)

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
por: Feng, Xiaomeng, et al.
Publicado: (2015)

Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levels
por: Ehx, Grégory, et al.
Publicado: (2014)

Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death
por: Paiva, Adriene A., et al.
Publicado: (2017)

Microarray analysis provides new insights into the function of apolipoprotein O in HepG2 cell line
por: Wu, Chen-Lu, et al.
Publicado: (2013)

ACSL1 affects Triglyceride Levels through the PPARγ Pathway
por: Li, Tingting, et al.
Publicado: (2020)

Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study
por: Komiya, Ichiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e6i72rasf4rghudjh3conhm7nc